V27. Risk in the Pharmaceutical Industry

Part of Anti-Corruption and Technology

Huge anti-corruption fines. A focus on corporate conduct. Globalization. Each of these trends has put a lot of pressure on third party management programs. In the OCEG Tech Talk, “Anti-Corruption and Technology,” Ken Kurtz, Dennis Haist, and Tony Charles from STEELE CIS share insight and advice on managing anti-corruption in third party relationships.

Part of Anti-Corruption and Technology

Huge anti-corruption fines. A focus on corporate conduct. Globalization. Each of these trends has put a lot of pressure on third party management programs. In the OCEG Tech Talk, “Anti-Corruption and Technology,” Ken Kurtz, Dennis Haist, and Tony Charles from STEELE CIS share insight and advice on managing anti-corruption in third party relationships.

V27. Risk in the Pharmaceutical Industry
Video filed in Information Technology

Third party risk and risk management in the pharmaceutical industry.

Share